Form 4: Elanco Animal Health Executive Trades Deferred Stock Units
Insider Transaction Report
Rajeev A. Modi, Executive Vice President at Elanco Animal Health, reported a transaction involving deferred stock units on June 12, 2026.
Summary
- Rajeev A. Modi, Executive Vice President of U.S. Pet Health and Global Digital Transformation at Elanco Animal Health Inc., engaged in a transaction involving deferred stock units.
- The transaction, dated June 12, 2026, involved the acquisition of 61.1059 deferred stock units.
- Each deferred stock unit is equivalent to one share of Elanco Animal Health's common stock or its cash equivalent.
- These units are set to settle in cash or shares of common stock upon termination of employment or in a specified future year, as per the Executive Deferral and Stock Match Plan.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard executive compensation transaction rather than a significant strategic event or financial performance indicator.
Positives
- The transaction indicates continued executive engagement and potential long-term incentive alignment with the company's performance through deferred stock units.
Future Outlook
The deferred stock units are subject to settlement upon termination of employment or during a specified future year, indicating a long-term incentive structure.
Industry Context
StockSavvy.ai notes that insider transactions, such as the reporting of deferred stock units, are common for executives in the animal health sector as part of their compensation and incentive structures.
Stakeholder Impact
- Shareholders: The transaction reflects standard executive compensation practices and does not immediately impact share value, but aligns executive interests with long-term company performance.
Next Steps
- Settlement of deferred stock units in cash or shares upon termination of employment or in a specified future year.
Key Dates
| Date | Description |
|---|---|
| 06/12/2026 | Earliest transaction date and settlement date for deferred stock units. |
| 06/16/2026 | Date the statement was signed. |
Keywords
Elanco Animal Health, ELAN, Form 4, Insider Trading, Deferred Stock Units, Executive Compensation, Securities Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.